Page 4 - Phantom Limb Pain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phantom limb pain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phantom Limb Pain Today - Breaking & Trending Today

Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain


Share this article
Share this article
CLEVELAND and ALISO VIEJO, Calif., Jan. 7, 2021 /PRNewswire/  Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain,  announced today the achievement of two milestones in its pivotal QUEST (High-Fre
QUEncy Nerve Block for Po
ST-Amputation Pain) study.  QUEST is a 180-subject, randomized, double blinded, active sham controlled clinical trial that is being conducted under an Investigational Device Exemption (IDE).  QUEST is designed to assess the safety & effectiveness of the Company s Altius
® High-Frequency Nerve Block system to treat intractable post-amputation pain. Post-amputation pain is a significant unmet medical need, as existing treatment options are limited, and consist primarily of opioids and gabapentinoids.  ....

United States , Kevin Kilgore , David Veino , Niloy Bhadra , Amy Smith , Neuros Medical Inc , National Principal Investigator , Data Monitoring Committee , Amputee Coalition , Company Altius , Carolinas Pain Institute , Case Western Reserve University , Neuros Medical , Nerve Block , Amputation Pain , Investigational Device Exemption , High Frequency Nerve Block , Leonardo Kapural , Neuros Chief Operating , Phantom Limb Pain , Residual Limb Pain , High Frequency Nerve , ஒன்றுபட்டது மாநிலங்களில் , கெவின் கில்கோர் , நிலோய் பத்ரா , ஆமி ஸ்மித் ,

Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain


Share this article
Share this article
CLEVELAND and ALISO VIEJO, Calif., Jan. 7, 2021 /PRNewswire/  Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 million. 
The financing was co-led by new investors Amzak Health and Sectoral Asset Management, joined by InCube Ventures, existing investors U.S. Venture Partners, Osage University Partners, and Aperture Venture Partners, and other existing and new investors. Joyce Erony of Amzak Health and Marc-Andre Marcotte of Sectoral Asset Management have joined Neuros Board of Directors.  Andrew Farquharson of InCube Ventures is serving as a Board Observer.  ....

United States , Kevin Kilgore , Marc Andre Marcotte , Niloy Bhadra , Joyce Erony , Andrew Farquharson , Tom Wilder , Amy Smith , Amzak Health , Neuros Medical Inc , Company Altius , Osage University Partners , Case Western Reserve University , Neuros Medical , Sectoral Asset Management , Incube Ventures , Aperture Venture Partners , Neuro Board , Nerve Block , Amputation Pain , Investigational Device Exemption , Frequency Nerve Block , Chief Executive , Phantom Limb Pain , Residual Limb Pain , High Frequency Nerve ,